tetano
Editor, Senior Moderator
MMWR Morb Mortal Wkly Rep. 2017 Jun 30;66(25):668-676. doi: 10.15585/mmwr.mm6625a3.
[h=1]Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine.[/h] Blanton L[SUP]1[/SUP], Alabi N[SUP]1[/SUP], Mustaquim D[SUP]1[/SUP], Taylor C[SUP]1[/SUP], Kniss K[SUP]1[/SUP], Kramer N[SUP]1[/SUP], Budd A[SUP]1[/SUP], Garg S[SUP]1[/SUP], Cummings CN[SUP]1[/SUP], Chung J[SUP]1[/SUP], Flannery B[SUP]1[/SUP], Fry AM[SUP]1[/SUP], Sessions W[SUP]1[/SUP], Garten R[SUP]1[/SUP], Xu X[SUP]1[/SUP], Elal AIA[SUP]1[/SUP], Gubareva L[SUP]1[/SUP], Barnes J[SUP]1[/SUP], Dugan V[SUP]1[/SUP], Wentworth DE[SUP]1[/SUP], Burns E[SUP]1[/SUP], Katz J[SUP]1[/SUP], Jernigan D[SUP]1[/SUP], Brammer L[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] During the 2016-17 influenza season (October 2, 2016-May 20, 2017) in the United States, influenza activity* was moderate. Activity remained low through November, increased during December, and peaked in February nationally, although there were regional differences in the timing of influenza activity. Influenza A(H3N2) viruses predominated through mid-March and were predominant overall for the season, but influenza B viruses were most commonly reported from late March through May. This report summarizes influenza activity in the United States during October 2, 2016-May 20, 2017[SUP]?[/SUP] and updates the previous summary (1).
PMID: 28662019 DOI: 10.15585/mmwr.mm6625a3
[h=1]Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine.[/h] Blanton L[SUP]1[/SUP], Alabi N[SUP]1[/SUP], Mustaquim D[SUP]1[/SUP], Taylor C[SUP]1[/SUP], Kniss K[SUP]1[/SUP], Kramer N[SUP]1[/SUP], Budd A[SUP]1[/SUP], Garg S[SUP]1[/SUP], Cummings CN[SUP]1[/SUP], Chung J[SUP]1[/SUP], Flannery B[SUP]1[/SUP], Fry AM[SUP]1[/SUP], Sessions W[SUP]1[/SUP], Garten R[SUP]1[/SUP], Xu X[SUP]1[/SUP], Elal AIA[SUP]1[/SUP], Gubareva L[SUP]1[/SUP], Barnes J[SUP]1[/SUP], Dugan V[SUP]1[/SUP], Wentworth DE[SUP]1[/SUP], Burns E[SUP]1[/SUP], Katz J[SUP]1[/SUP], Jernigan D[SUP]1[/SUP], Brammer L[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] During the 2016-17 influenza season (October 2, 2016-May 20, 2017) in the United States, influenza activity* was moderate. Activity remained low through November, increased during December, and peaked in February nationally, although there were regional differences in the timing of influenza activity. Influenza A(H3N2) viruses predominated through mid-March and were predominant overall for the season, but influenza B viruses were most commonly reported from late March through May. This report summarizes influenza activity in the United States during October 2, 2016-May 20, 2017[SUP]?[/SUP] and updates the previous summary (1).
PMID: 28662019 DOI: 10.15585/mmwr.mm6625a3